Standard InChI: InChI=1S/C20H23N3O2S2/c1-19(2)12-20(3,4)27-17-10-7-14(11-16(17)19)22-18(26)21-13-5-8-15(9-6-13)23(24)25/h5-11H,12H2,1-4H3,(H2,21,22,26)
Standard InChI Key: FWWKIYPMUZVMQG-UHFFFAOYSA-N
Associated Targets(Human)
Caov-3 cell line 328 Activities
Activity Type
Relation
Activity value
Units
Action Type
Journal
PubMed Id
doi
Assay Aladdin ID
OVCAR-3 48710 Activities
Activity Type
Relation
Activity value
Units
Action Type
Journal
PubMed Id
doi
Assay Aladdin ID
SK-OV-3 52876 Activities
Activity Type
Relation
Activity value
Units
Action Type
Journal
PubMed Id
doi
Assay Aladdin ID
MCF7 126967 Activities
Activity Type
Relation
Activity value
Units
Action Type
Journal
PubMed Id
doi
Assay Aladdin ID
T47D 39041 Activities
Activity Type
Relation
Activity value
Units
Action Type
Journal
PubMed Id
doi
Assay Aladdin ID
MDA-MB-453 1139 Activities
Activity Type
Relation
Activity value
Units
Action Type
Journal
PubMed Id
doi
Assay Aladdin ID
DU-145 51482 Activities
Activity Type
Relation
Activity value
Units
Action Type
Journal
PubMed Id
doi
Assay Aladdin ID
LNCaP 8286 Activities
Activity Type
Relation
Activity value
Units
Action Type
Journal
PubMed Id
doi
Assay Aladdin ID
A2780 11979 Activities
Activity Type
Relation
Activity value
Units
Action Type
Journal
PubMed Id
doi
Assay Aladdin ID
Stress-70 protein, mitochondrial 43 Activities
Activity Type
Relation
Activity value
Units
Action Type
Journal
PubMed Id
doi
Assay Aladdin ID
Associated Targets(non-human)
Rattus norvegicus 775804 Activities
Activity Type
Relation
Activity value
Units
Action Type
Journal
PubMed Id
doi
Assay Aladdin ID
Plasma 6361 Activities
Activity Type
Relation
Activity value
Units
Action Type
Journal
PubMed Id
doi
Assay Aladdin ID
Canis familiaris 36305 Activities
Activity Type
Relation
Activity value
Units
Action Type
Journal
PubMed Id
doi
Assay Aladdin ID
Molecule Features
Natural Product: No
Oral: No
Chemical Probe: No
Parenteral: No
Molecule Type: Small molecule
Topical: No
First In Class: No
Black Box: No
Chirality: Yes
Availability: No
Prodrug: No
Drug Indications
MESH ID
MESH Heading
EFO IDs
EFO Terms
Max Phase for Indication
References
Mechanisms of Action
Mechanism of Action
Action Type
target ID
Target Name
Target Type
Target Organism
Binding Site Name
References
Properties
Molecular Weight: 401.56
Molecular Weight (Monoisotopic): 401.1232
AlogP: 5.96
#Rotatable Bonds: 3
Polar Surface Area: 67.20
Molecular Species: NEUTRAL
HBA: 4
HBD: 2
#RO5 Violations: 1
HBA (Lipinski): 5
HBD (Lipinski): 2
#RO5 Violations (Lipinski): 1
CX Acidic pKa: 12.63
CX Basic pKa:
CX LogP: 6.03
CX LogD: 6.03
Aromatic Rings: 2
Heavy Atoms: 27
QED Weighted: 0.38
Np Likeness Score: -1.19
References
1.Liu S, Brown CW, Berlin KD, Dhar A, Guruswamy S, Brown D, Gardner GJ, Birrer MJ, Benbrook DM.. (2004) Synthesis of flexible sulfur-containing heteroarotinoids that induce apoptosis and reactive oxygen species with discrimination between malignant and benign cells., 47 (4):[PMID:14761202][10.1021/jm030346v]
2.Liu S, Louie MC, Rajagopalan V, Zhou G, Ponce E, Nguyen T, Green L.. (2015) Synthesis and evaluation of the diarylthiourea analogs as novel anti-cancer agents., 25 (6):[PMID:25701251][10.1016/j.bmcl.2015.01.042]
3.Gnanasekaran KK, Benbrook DM, Nammalwar B, Thavathiru E, Bunce RA, Berlin KD.. (2015) Synthesis and evaluation of second generation Flex-Het scaffolds against the human ovarian cancer A2780 cell line., 96 [PMID:25880346][10.1016/j.ejmech.2015.03.070]
4.Watts FM, Pouland T, Bunce RA, Berlin KD, Benbrook DM, Mashayekhi M, Bhandari D, Zhou D.. (2018) Activity of oxygen-versus sulfur-containing analogs of the Flex-Het anticancer agent SHetA2., 158 [PMID:30245396][10.1016/j.ejmech.2018.09.036]
5.Nammalwar B, Bunce RA, Berlin KD, Benbrook DM, Toal C.. (2019) Synthesis and biological evaluation of SHetA2 (NSC-721689) analogs against the ovarian cancer cell line A2780., 170 [PMID:30878829][10.1016/j.ejmech.2019.03.010]
6.Gnanasekaran KK, Pouland T, Bunce RA, Darrell Berlin K, Abuskhuna S, Bhandari D, Mashayekhi M, Zhou DH, Benbrook DM.. (2020) Tetrahydroquinoline units in flexible heteroarotinoids (Flex-Hets) convey anti-cancer properties in A2780 ovarian cancer cells., 28 (1):[PMID:31831296][10.1016/j.bmc.2019.115244]